Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System
The traditional approach to the treatment of advanced non-small cell lung cancer (NSCLC) relied on the uniform use of cytotoxic chemotherapy. Over the last eight years, this paradigm of care has been shifting towards the use of molecularly targeted agents. Epidermal growth factor receptor (EGFR) mut...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
MDPI
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251366/ |